Cellectis announced the appointment of Dr. Loan Hoang-Sayag to the role of Chief Medical Officer. Dr. Hoang-Sayag's responsibilities will include bringing the company's product candidates into clinical stage development, as well as strategic and operational management of all therapeutic activities for Cellectis. Dr. Hoang-Sayag joins Cellectis from Quintiles Transnational, where she was most recently Senior Director of Medical Science.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.95 EUR | -7.36% | -17.37% | -29.45% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.45% | 209M | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- ALCLS Stock
- News Cellectis S.A.
- Cellectis Appoints Dr. Loan Hoang-Sayag to the Role of Chief Medical Officer